Wei Wen-Qiang, Chen Zhi-Feng, He Yu-Tong, Feng Hao, Hou Jun, Lin Dong-Mei, Li Xin-Qing, Guo Cui-Lan, Li Shao-Sen, Wang Guo-Qing, Dong Zhi-Wei, Abnet Christian C, Qiao You-Lin
Wen-Qiang Wei, Hao Feng, Dong-Mei Lin, Xin-Qing Li, Guo-Qing Wang, Zhi-Wei Dong, and You-Lin Qiao, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing; Zhi-Feng Chen, Yu-Tong He, and Jun Hou, Cancer Institute of Hebei Province, Shijiazhuang; Cui-Lan Guo, Shao-Sen Li, Cancer Institute/Hospital of Ci County, Handan, China; and Christian C. Abnet, National Cancer Institute, Bethesda, MD.
J Clin Oncol. 2015 Jun 10;33(17):1951-7. doi: 10.1200/JCO.2014.58.0423. Epub 2015 May 4.
There are no global screening recommendations for esophageal squamous cell carcinoma (ESCC). Endoscopic screening has been investigated in areas of high incidence in China since the 1970s. This study aimed to evaluate whether an endoscopic screening and intervention program could reduce mortality caused by ESCC.
Residents age 40 to 69 years were recruited from communities with high rates of ESCC. Fourteen villages were selected as the intervention communities. Ten villages not geographically adjacent to intervention villages were selected for comparison. Participants in the intervention group were screened once by endoscopy with Lugol's iodine staining, and those with dysplasia or occult cancer were treated. All intervention participants and a sample consisting of one tenth of the control group completed questionnaires. We compared cumulative ESCC incidence and mortality between the two groups.
Three thousand three hundred nineteen volunteers (48.62%) from an eligible population of 6,827 were screened in the intervention group. Seven hundred ninety-seven volunteers from an eligible population of 6,200 in the control group were interviewed. Six hundred fifty-two incident and 542 fatal ESCCs were identified during the 10-year follow-up. A reduction in cumulative mortality in the intervention group versus the control group was apparent (3.35% v 5.05%, respectively; P < .001). Furthermore, the intervention group had a significantly lower cumulative incidence of ESCC versus the control group (4.17% v 5.92%, respectively; P < .001).
We showed that endoscopic screening and intervention significantly reduced mortality caused by esophageal cancer. Detection and treatment of preneoplastic lesions also led to a reduction in the incidence of this highly fatal cancer.
目前尚无针对食管鳞状细胞癌(ESCC)的全球筛查建议。自20世纪70年代以来,中国高发地区已开展了内镜筛查研究。本研究旨在评估内镜筛查与干预计划是否能降低ESCC所致死亡率。
从ESCC高发社区招募40至69岁的居民。选择14个村庄作为干预社区。选择10个与干预村不相邻的村庄作为对照。干预组参与者接受一次卢戈氏碘染色内镜筛查,对发育异常或隐匿性癌患者进行治疗。所有干预参与者和对照组十分之一的样本完成问卷调查。我们比较了两组之间ESCC的累积发病率和死亡率。
干预组对符合条件的6827名志愿者中的3319名(48.62%)进行了筛查。对照组对符合条件的6200名志愿者中的797名进行了访谈。在10年随访期间,共发现652例ESCC发病病例和542例ESCC死亡病例。干预组的累积死亡率明显低于对照组(分别为3.35%和5.05%;P<.001)。此外,干预组的ESCC累积发病率也显著低于对照组(分别为4.17%和5.92%;P<.001)。
我们表明,内镜筛查与干预显著降低了食管癌所致死亡率。癌前病变的检测与治疗也降低了这种高致命性癌症的发病率。